Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

2.

Promyelocytic leukemia protein (PML) regulates endothelial cell network formation and migration in response to tumor necrosis factor α (TNFα) and interferon α (IFNα).

Cheng X, Liu Y, Chu H, Kao HY.

J Biol Chem. 2012 Jul 6;287(28):23356-67. doi: 10.1074/jbc.M112.340505. Epub 2012 May 15.

3.

Translational control of PML contributes to TNFα-induced apoptosis of MCF7 breast cancer cells and decreased angiogenesis in HUVECs.

Hsu KS, Guan BJ, Cheng X, Guan D, Lam M, Hatzoglou M, Kao HY.

Cell Death Differ. 2016 Mar;23(3):469-83. doi: 10.1038/cdd.2015.114. Epub 2015 Sep 18.

4.

Histone deacetylase 7 promotes PML sumoylation and is essential for PML nuclear body formation.

Gao C, Ho CC, Reineke E, Lam M, Cheng X, Stanya KJ, Liu Y, Chakraborty S, Shih HM, Kao HY.

Mol Cell Biol. 2008 Sep;28(18):5658-67. doi: 10.1128/MCB.00874-08. Epub 2008 Jul 14.

5.

Promyelocytic leukemia protein is a cell-intrinsic factor inhibiting parvovirus DNA replication.

Mitchell AM, Hirsch ML, Li C, Samulski RJ.

J Virol. 2014 Jan;88(2):925-36. doi: 10.1128/JVI.02922-13. Epub 2013 Nov 6.

6.

Promyelocytic leukemia protein sensitizes tumor necrosis factor alpha-induced apoptosis by inhibiting the NF-kappaB survival pathway.

Wu WS, Xu ZX, Hittelman WN, Salomoni P, Pandolfi PP, Chang KS.

J Biol Chem. 2003 Apr 4;278(14):12294-304. Epub 2003 Jan 22.

7.

Promyelocytic leukemia (PML) protein plays important roles in regulating cell adhesion, morphology, proliferation and migration.

Tang MK, Liang YJ, Chan JY, Wong SW, Chen E, Yao Y, Gan J, Xiao L, Leung HC, Kung HF, Wang H, Lee KK.

PLoS One. 2013;8(3):e59477. doi: 10.1371/journal.pone.0059477. Epub 2013 Mar 21.

8.

The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein.

Guan D, Factor D, Liu Y, Wang Z, Kao HY.

Oncogene. 2013 Aug 15;32(33):3819-28. doi: 10.1038/onc.2012.406. Epub 2012 Sep 3. Erratum in: Oncogene. 2015 Oct 1;34(40):5206.

9.

Promyelocytic Leukemia Protein Isoform II Promotes Transcription Factor Recruitment To Activate Interferon Beta and Interferon-Responsive Gene Expression.

Chen Y, Wright J, Meng X, Leppard KN.

Mol Cell Biol. 2015 May;35(10):1660-72. doi: 10.1128/MCB.01478-14. Epub 2015 Mar 2.

10.

β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.

Satow R, Shitashige M, Jigami T, Fukami K, Honda K, Kitabayashi I, Yamada T.

Gastroenterology. 2012 Mar;142(3):572-81. doi: 10.1053/j.gastro.2011.11.041. Epub 2011 Dec 9.

PMID:
22155184
11.

Control of antioxidative response by the tumor suppressor protein PML through regulating Nrf2 activity.

Guo S, Cheng X, Lim JH, Liu Y, Kao HY.

Mol Biol Cell. 2014 Aug 15;25(16):2485-98. doi: 10.1091/mbc.E13-11-0692. Epub 2014 Jun 18.

12.

SCP phosphatases suppress renal cell carcinoma by stabilizing PML and inhibiting mTOR/HIF signaling.

Lin YC, Lu LT, Chen HY, Duan X, Lin X, Feng XH, Tang MJ, Chen RH.

Cancer Res. 2014 Dec 1;74(23):6935-46. doi: 10.1158/0008-5472.CAN-14-1330. Epub 2014 Oct 7.

13.

AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.

Li Q, He Y, Wei L, Wu X, Wu D, Lin S, Wang Z, Ye Z, Lin SC.

Oncogene. 2011 Mar 10;30(10):1194-204. doi: 10.1038/onc.2010.499. Epub 2010 Nov 8.

PMID:
21057547
14.

Interleukin 6 signaling regulates promyelocytic leukemia protein gene expression in human normal and cancer cells.

Hubackova S, Krejcikova K, Bartek J, Hodny Z.

J Biol Chem. 2012 Aug 3;287(32):26702-14. doi: 10.1074/jbc.M111.316869. Epub 2012 Jun 18.

15.

Promyelocytic leukemia inhibits adipogenesis, and loss of promyelocytic leukemia results in fat accumulation in mice.

Kim MK, Yang S, Lee KH, Um JH, Liu M, Kang H, Park SJ, Chung JH.

Am J Physiol Endocrinol Metab. 2011 Dec;301(6):E1130-42. doi: 10.1152/ajpendo.00092.2011. Epub 2011 Aug 16.

16.

Regulation of the PML tumor suppressor in drug-induced senescence of human normal and cancer cells by JAK/STAT-mediated signaling.

Hubackova S, Novakova Z, Krejcikova K, Kosar M, Dobrovolna J, Duskova P, Hanzlikova H, Vancurova M, Barath P, Bartek J, Hodny Z.

Cell Cycle. 2010 Aug 1;9(15):3085-99. doi: 10.4161/cc.9.15.12521. Epub 2010 Aug 26.

PMID:
20699642
17.

Colorectal cancer cell-derived microvesicles containing microRNA-1246 promote angiogenesis by activating Smad 1/5/8 signaling elicited by PML down-regulation in endothelial cells.

Yamada N, Tsujimura N, Kumazaki M, Shinohara H, Taniguchi K, Nakagawa Y, Naoe T, Akao Y.

Biochim Biophys Acta. 2014 Nov;1839(11):1256-72. doi: 10.1016/j.bbagrm.2014.09.002. Epub 2014 Sep 10.

PMID:
25218966
18.

Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies.

Reineke EL, Kao HY.

Int J Biol Sci. 2009 May 22;5(4):366-76. Review.

19.

Mitogen-activated protein kinase extracellular signal-regulated kinase 2 phosphorylates and promotes Pin1 protein-dependent promyelocytic leukemia protein turnover.

Lim JH, Liu Y, Reineke E, Kao HY.

J Biol Chem. 2011 Dec 30;286(52):44403-11. doi: 10.1074/jbc.M111.289512. Epub 2011 Oct 27.

20.

PML positively regulates interferon gamma signaling.

El Bougrini J, Dianoux L, Chelbi-Alix MK.

Biochimie. 2011 Mar;93(3):389-98. doi: 10.1016/j.biochi.2010.11.005. Epub 2010 Nov 27.

PMID:
21115099

Supplemental Content

Support Center